Showing 1 - 10 of 8,431
Persistent link: https://www.econbiz.de/10014374380
Persistent link: https://www.econbiz.de/10014374515
) is the unique SPNE policy choice. The welfare properties reveal that although innovation may be higher at the (Strict IPR …
Persistent link: https://www.econbiz.de/10010277807
Apart from the basic statutory definition in section 65 of the Intellectual Property Act of Sri Lanka, there do not appear to be any detailed statutory guidelines or judicial decisions to provide any framework for the assessment of inventive step in Sri Lanka. The current statutory definition is...
Persistent link: https://www.econbiz.de/10014374718
innovation. We evaluate this argument in a dynamic stochastic model of a patent race. The result generally supports the …
Persistent link: https://www.econbiz.de/10010332206
The aim of this paper is to test whether patent-based indicators are still reliable measures of innovativeness in light of organizational changes in the field of Intellectual Property Rights (IPR) protection and the regulatory reforms already under way respectively at the U.S. Patent and...
Persistent link: https://www.econbiz.de/10010263794
The US and the EU recently introduced regulation to curb the extent of risky off-label drug use. It offers manufacturers a prolongation of patent protection or exclusivity if they invest in pediatric clinical tests. This paper shows that a reinforcement of physician liability for off-label use...
Persistent link: https://www.econbiz.de/10010265794
important role in reducing the burden on health budgets and increase access to more affordable pharmaceuticals. …
Persistent link: https://www.econbiz.de/10012490840
"Viral hepatitis is an international public health challenge, comparable to other major communicable diseases, including HIV, tuberculosis and malaria. Despite the significant burden it places on communities across all global regions, hepatitis has been largely ignored as a health and...
Persistent link: https://www.econbiz.de/10012490851